Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Abbott Up 7.7% Post Q2 Earnings: Should You Buy ABT Stock?
12:51pm, Tuesday, 13'th Aug 2024
Abbott's (ABT) strong growth projection for 2024 is an indication that the stock will be able to sustain the positive momentum through the rest of the year.
Abbott Laboratories: Driving Value By Scaling Innovations
07:09am, Tuesday, 13'th Aug 2024
Abbott Laboratories is a diversified healthcare supplier with a focus on medical devices, nutrition, diagnostics, and pharmaceuticals. The company experienced a surge in share price due to COVID-19 te
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?
08:29pm, Monday, 12'th Aug 2024
An analyst from Barclays recently increased his price target for Abbott Laboratories to $143 per share. The raised target implies a gain of more than 30% from recent prices.
Trade Tracker: Karen Firestone buys Abbott Labs, Chemed, Costar Group and sells Home Depot
01:16pm, Wednesday, 07'th Aug 2024
Karen Firestone, chairman and CEO at Aureus Asset Management, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
10:02am, Wednesday, 07'th Aug 2024
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Drugmaker Abbott India's Q1 profit climbs on higher sales, price hikes
09:06am, Wednesday, 07'th Aug 2024
Drugmaker Abbott India reported a rise in first-quarter profit on Wednesday, helped by higher sales and price hikes.
Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices
08:00am, Wednesday, 07'th Aug 2024
Unique partnership with Medtronic will enable continuous glucose monitoring (CGM) sensors based on Abbott's FreeStyle Libre sensing technology to integrate with Medtronic's insulin delivery systems A
3 Dividend Growth Stocks to Buy Hand Over Fist in August
05:10am, Wednesday, 07'th Aug 2024
Abbott Labs is a proven wealth builder at a fair price. Johnson & Johnson's a safe buy despite its ongoing litigation.
Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs
09:00am, Tuesday, 06'th Aug 2024
PONTE VEDRA, Fla., Aug. 6, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage, new-generation Vitamin K Antagonist (VKA
Abbott Laboratories: A Strong Healthcare Stock For Long-Term Dividend Growth Investors
10:30am, Monday, 05'th Aug 2024
Abbott Laboratories is now a $183 billion (by market cap) healthcare titan. Abbott Laboratories has increased its dividend for more than 50 consecutive years. So it has the kind of dividend growth ped
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
06:45am, Saturday, 03'rd Aug 2024
Abbott Laboratories and Gilead Sciences are solid dividend stocks. Both look a bit pricey relative to their recent financial results.
Abbott (ABT) Just Overtook the 200-Day Moving Average
10:32am, Friday, 02'nd Aug 2024
Abbott (ABT) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ABT broke through the 200-day moving average, which suggests a long-ter
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
08:00am, Friday, 02'nd Aug 2024
The diabetes donnybrook between Abbott Laboratories and Dexcom is poised to heat up — and could bolster both Abbott stock and Dexcom stock.
Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth
05:17am, Friday, 02'nd Aug 2024
Johnson & Johnson has been generating decent growth, but legal challenges could create a lot of uncertainty. Abbott Laboratories has a more diverse business, with some exciting opportunities in diabet
7 Leading MedTech Stocks for Next-Gen Health Solutions
02:30pm, Wednesday, 31'st Jul 2024
While technology lately has been framed in the context of computer hardware or software, it can also apply to the broader field of medicine. Therefore, investors should consider the viable field of Me
